Canada markets closed

MedMen Enterprises Inc. (MMEN.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.01500.0000 (0.00%)
At close: 04:12PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 20.75M
Enterprise Value 524.79M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.23
Price/Book (mrq)0.12
Enterprise Value/Revenue 3.22
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.40
52-Week Change 3-57.14%
S&P500 52-Week Change 328.04%
52 Week High 30.0500
52 Week Low 30.0150
50-Day Moving Average 30.0150
200-Day Moving Average 30.0215

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 51.38B
Implied Shares Outstanding 61.84B
Float 81.36B
% Held by Insiders 11.31%
% Held by Institutions 12.26%
Shares Short (Apr 15, 2024) 411.66k
Short Ratio (Apr 15, 2024) 4N/A
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.00%
Shares Short (prior month Mar 15, 2024) 411.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:9.2623
Last Split Date 3May 28, 2018

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends N/A
Most Recent Quarter (mrq)N/A


Profit Margin -112.21%
Operating Margin (ttm)-34.78%

Management Effectiveness

Return on Assets (ttm)-6.28%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)120.12M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)-22.80%
Gross Profit (ttm)N/A
EBITDA -14.41M
Net Income Avi to Common (ttm)-143.31M
Diluted EPS (ttm)-0.1500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.63M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)379.18M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.19
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-20.35M
Levered Free Cash Flow (ttm)-60.32M